Fortress Biotech, Inc. (FBIO) investor relations documents from the company's IR site: 4 presentations, 26 press releases; latest deck 2025-05-01. Read in-app with summaries. First-party data.
https://d1io3yog0oux5.cloudfront.net/_63c040843790e23b346025bad547093c/fortressbiotech/db/640/6122/pdf/Cellvation_Corporate+Deck+%28May+2025%29.pdf: Fortress Biotech subsidiary developing CEVA-D, a bioreactor that enhances MSC potency to reduce cell therapy costs by up to 75% and improve clinical efficacy.
FBIO overview · FBIO earnings · FBIO financials · FBIO KPIs · FBIO ownership · FBIO peers · FBIO filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.